EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Development and Optimization of an Eplerenone-Loaded Liposomal In Situ Gel for Enhanced Intranasal Delivery

Juste Baranauskaite iD, Ipek Ceken, Asta Kubiliene iD, Rima Jurate Gerbutaviciene, Ebru Türköz Acar, Cetin Tas

Pharmaceutics · 29.05.2026 · 18 (6) · 678

DOI: 10.3390/pharmaceutics18060678 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 29.05.2026. Verfasst von Juste Baranauskaite und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Technology, Faculty of Pharmacy, Yeditepe University, 34755 Istanbul, Turkey. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives: this study aimed to develop and optimize an intranasal delivery system for Eplerenone (EPL) by incorporating Eplerenone-loaded liposomes (Elip) into an in situ gel system (Elip-GG). The goal was to prolong the residence time of the drug in the nasal cavity and ensure sustained release. Methods: Elip and unloaded liposomes were prepared using the thin-film hydration method. Key formulation variables such as encapsulation efficiency (EE%), mean particle size (MPS), polydispersity index (PDI), and zeta potential (ZP) were optimized. The Elip was then incorporated into a gellan gum (GG) in situ gel to form Elip-GG. The Elip-GG formulation was evaluated based on parameters such as pH, viscosity, rheological behavior, mechanical properties, and in vitro release. Results: the optimal Elip formulation exhibited an EE of 86.3%, a mean particle size of 86.56 nm, a PDI of 0.29, and a ZP of −29.86 mV. The cumulative drug release from the Elip-GG formulation exceeded 93% after 2.5 h. The Elip-GG formulation significantly increased the sustained release of Eplerenone when administered intranasally, offering a promising alternative to oral and parenteral delivery methods for hydrophilic antihypertensive drugs.

Schlagwörter

Stichwörter der Autor:innen

Eplerenonecomputational analysisencapsulation efficiencyin situ gelintranasal deliveryliposomes

Autor:innen und Institutionen

  • Department of Pharmaceutical Technology, Faculty of Pharmacy, Yeditepe University, 34755 Istanbul, Turkey.
  • Department of Analytical and Toxicological Chemistry, Faculty of Pharmacy, Academy of Medicine, Lithuanian University of Health Sciences, 50162 Kaunas, Lithuania.
  • Department of Drug Technology and Social Pharmacy, Faculty of Pharmacy, Academy of Medicine, Lithuanian University of Health Sciences, 50162 Kaunas, Lithuania.
  • Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Yeditepe University, 34755 Istanbul, Turkey.

ORCID-Profile: Juste Baranauskaite, Asta Kubiliene

Zitieren

APA

Baranauskaite, J., Ceken, I., Kubiliene, A., Gerbutaviciene, R. J., Türköz Acar, E., & Tas, C. (2026). Development and Optimization of an Eplerenone-Loaded Liposomal In Situ Gel for Enhanced Intranasal Delivery. Pharmaceutics, 18(6), 678. https://doi.org/10.3390/pharmaceutics18060678

Vancouver

Baranauskaite J, Ceken I, Kubiliene A, Gerbutaviciene RJ, Türköz Acar E, Tas C. Development and Optimization of an Eplerenone-Loaded Liposomal In Situ Gel for Enhanced Intranasal Delivery. Pharmaceutics. 2026;18(6):678. doi:10.3390/pharmaceutics18060678

BibTeX
@article{Baranauskaite2026,
  author = {Baranauskaite, Juste and Ceken, Ipek and Kubiliene, Asta and Gerbutaviciene, Rima Jurate and Türköz Acar, Ebru and Tas, Cetin},
  title = {Development and Optimization of an Eplerenone-Loaded Liposomal In Situ Gel for Enhanced Intranasal Delivery},
  journal = {Pharmaceutics},
  year = {2026},
  volume = {18},
  number = {6},
  pages = {678},
  doi = {10.3390/pharmaceutics18060678}
}
Kostenlos starten →